ArticleNeurotrauma reports
Oral Contraceptives, Concussion History, and Contact-Sport Exposure: Multimodal MRI and Brain Injury Biomarkers in Female Athletes.
Article in Neurotrauma reports. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Neuroimaging and blood-based biomarkers are increasingly utilized to identify long-term effects of concussion and contact-sport exposure (CSE), but female athletes are underrepresented in this work, despite potential sex-related differences. Early research indicates that widely used oral contraceptives (OCs) influence brain structure and function and concussion-related biomarkers. This study investigated whether current oral contraceptive (OC) use moderates associations of concussion history and CSE with magnetic resonance imaging (MRI) measures and brain injury biomarkers in female athletes. Part of a larger cross-sectional study, 68 collegiate-aged female athletes (30 OC users, 38 with no hormonal contraceptive use [NoHC]), completed interviews to retrospectively determine the number of prior concussions (last injury at least 6 months before study enrollment) and years of CSE. Serum glial fibrillary acidic protein, neurofilament light, and total tau levels were measured, along with hippocampal volume, cortical thickness, and Neurite Orientation Dispersion and Density Imaging metrics. Linear regression and Bayesian multilevel modeling tested interactions between OC use and concussion history or CSE on outcomes. Number of prior concussions was negatively associated with hippocampal volumes and cortical thickness. OC use moderated relationships between CSE and cortical thickness, isotropic volume fraction (ISO), and intracellular volume fraction, and between concussion history and orientation dispersion index (ODI). OC users had lower tau levels than the NoHC group. Exploratory models suggested OC pill formulation may moderate associations of concussion history and/or CSE with outcomes and directly affect cortical thickness, ODI, and ISO. These results suggest OC use deserves consideration as an influencing factor in future research and personalized treatment for female athletes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.